Short stories

New coworking space to open, Houston to host Accenture's health tech awards, and more innovation news

Spaces plans to open a new location in Houston this month, Chevron Technology Ventures invests in autonomous vehicle tech, and more Houston innovation news. Courtesy of Spaces

A lot is happening in the Houston innovation ecosystem — so much that you may have missed a few key news items. Let's hit the highlights, shall we?

Applications are open for major health tech awards program that is coming to town, a Houston corporate venture fund doles out cash to self-driving cars, new coworking space to deliver, a diversity-focused partnership launches, and more Houston innovation news.

Chevron Technology Ventures invests in self-driving cars

Voyage is growing its fleet of self-driving vehicles with the help of a Houston corporate VC fund. Photo via voyage.auto

Silicon Valley's Voyage, a self-driving car technology company, closed its series B round at $31 million. Houston-based Chevron Technology Ventures contributed to the round.

The round's funds will go toward expanding the company's fleet of G2 autonomous vehicles in California and Florida, as well as introduce Voyage's G3 self-driving car, Oliver Cameron, co-founder and CEO at Voyage, writes in a release.

"Chevron has been supporting the public's transportation needs for over 100 years. As our customers' mobility needs and preferences change, we want to continue to be part of their journeys. Our investment in Voyage affirms this commitment," says Barbara Burger, CTV president, in a release. "We established the Future Energy Fund in 2018 with an initial commitment of $100 million to invest in breakthrough technologies that enable the ongoing energy transition. The fund looks for technologies that lower emissions and support low carbon value chains. Our investment in Voyage fits well within the objectives of the Future Energy Fund while also informing our perspective on the changing energy landscape."

Accenture to close out health tech challenge in Houston

accenture

The national challenge will conclude in Houston. Courtesy of Accenture

Applications are open for the fourth annual Accenture HealthTech Innovation Challenge and close on September 22. Finalists will present to judges from global health companies at one of two regional events — in Boston on Nov. 7 or in San Francisco on Dec. 5. The final judging event will take place in Houston on February 6, 2020.

"We look forward to this year's submissions as we continue to identify bold ideas from startups that deliver new solutions for health organizations to improve the lives of consumers, clinicians and employees," says Brian Kalis, managing director of digital health and innovation at Accenture, in a release. "Since its inception, the Accenture HealthTech Innovation Challenge has brought healthcare organizations and startups together to tackle the world's biggest health issues where we have received more than 2,200 applications, invited more than 90 startups to compete and who have benefitted from the guidance of nearly 1,000 executive judges from the healthcare industry."

The submission form, including additional details about the challenge's criteria, eligibility, and requirements, is available at: Accenture HealthTech Innovation Challenge-Health.

GotSpot wins pitch competition

Reda Hicks claimed the win at a military spouse pitch event. Trish Alegre-Smith/Military.com

Reda Hicks, who founded Houston-based GotSpot Inc., won a $15,000 check from the StreetShares Foundation and Samuel Adams' Brewing the American Dream at the Great American Military Entrepreneur at the Military Influencer Conference in Washington, D.C.

GotSpot is a website that allows for people with commercial space — a commercial kitchen, conference room, spare desks, etc. — to list it. Then, space seekers — entrepreneurs, nonprofits, freelancers, etc. — can rent it.

"This award is a game-changer for me," Hicks says to Military.com. "This will allow me to hire more incredible military spouses and help GotSpot on its path to go global."

Rice University launches new sports business course

Rice University

Rice University has a new sports business program. Photo courtesy of Rice University

Rice University, along with the Houston Texans, is introducing a new program for the university's sport management students. Pro Sports: Management is a course designed to teach the business side of the sports world.

"We are thrilled to partner with Rice University on a curriculum that will provide their best and brightest students with insight into the real-world opportunities and challenges facing today's sports teams," says Houston Texans President Jamey Rootes in a release from Rice. "This program is rather unique because our leading executives will work alongside Rice professors to teach current best practices in franchise management across every discipline. We believe that this type of practical industry exposure is the best way to prepare the next generation of leaders in the field of sports management and a valuable contribution to the level of professionalism within our industry."

The classes will be held weekly in the executive offices of the Texans. The course will cover ticketing, public relations, event management, human resources and more.

Spaces plans to open second coworking location in Houston

Spaces, an Amsterdam-based coworking space company that entered the Houston market with a lease in Kirby Grove announced in 2017, plans to open its newest location this month. Courtesy of Spaces

The new Spaces CityCentre One location is planned to open on Monday, September 30. It's the Amsterdam-based company's second coworking space in Houston, with a third already in the works. The first location was in Kirby Grove in 2017, and Spaces Galleria at Post Oak will be opening in the second quarter of 2020.

The CityCentre One location will have over 60,000 square-feet of workspace with perks, including a business club, dedicated desk space, private offices, and seven fully-equipped meeting rooms. Plus, the building is just steps away from CityCentre, a mixed-use development with restaurants, entertainment, housing, and more. Membership pricing starts at $111 a month at the new location.

Cemvita Factory receives more backing from oil and gas industry

Cemvita FactoryCemvita Factory

Houston-based Cemvita Factory, a biotech company that can mimick photosynthesis and convert CO2 into glucose and other substances, has received equity investment from BHP. The amount of the investment was not disclosed.

The investment will help Cemvita Factory continue to develop its biomimicry technology for oil and gas applications to reduce the volume of greenhouse gas emissions.

"This strategic investment fits well with BHP's vision of the future: reducing operational greenhouse gas emissions, reducing environmental impact and the development of low-emissions technology, including increased application of carbon capture, utilization and storage technology," says BHP's chief geoscientist, Laura Tyler, in a release.

Last month, Occidental Petroleum's low carbon subsidiary, Oxy Low Carbon Ventures LLC, announced it invested an undisclosed amount of funds into Cemvita Factory.

Two organizations join forces to promote diversity in the Houston Startup Scene

Impact Hub Houston and The Cannon have teamed up to grow programming and events surrounding diversity. Photo courtesy of The Cannon

In an effort to promote diversity and inclusion within the Houston innovation ecosystem, The Cannon and Impact Hub Houston have teamed up. The collaboration will drive programming and events geared at growing the conversation and resources for startups and entrepreneurs.

"One of Houston's best differentiating qualities is that we are truly a melting pot," says Lawson Gow, founder and CEO of The Cannon, in a news release. "We want our community to reflect the amazing diversity across our city, so we have to move beyond simply discussing diversity and work to create an environment where innovation can thrive and real change can happen. We are confident Impact Hub will be the perfect partner to bring those aspects to our community."

Gow, who is the son of InnovationMap's parent company's CEO, opened the doors to its new 120,000-square-foot facility in July. Impact Hub Houston will have a presence in the space.

"Over the past few years, Lawson and I have brainstormed how we could work together to connect and grow our region's innovation ecosystem and demonstrate how organizations can evolve from competition to true collaboration," says Grace Rodriguez, CEO and Executive Director of Impact Hub Houston, in the release. "I'm so excited that those talks have developed into this partnership: Through The Cannon and Impact Hub Houston, we'll be able to effectively 'meet people where they are' geographically, socially, and culturally, helping diverse entrepreneurs and startups at the myriad intersections of place, purpose, demographics, psychographics, and business growth stages."

Houston innovator nominated for prestigious Silicon Valley award

Alley Lyles is up for an award for her work in digital transformation.

Alley Lyles, digital transformation manager at Direct Energy and Houston startup mentor, was nominated for a Women in IT - Silicon Valley award as Transformation Leader of the Year. The awards event is on October 9.

She is up against Emily Dunn at Anaplan, Windy Garrett at Atos, Manju Abraham at Delphix, Aashima Gupta at Google, Patricia Grant at ServiceNow, and Nataliya Anon at Svitla Systems.

"I am proud to represent Houston in Silicon Valley. The Houston hustle is real. I see it amongst my colleagues who got me here. The hustle isn't always glamorous, so I appreciate the moment when a kid from the East End can shine."

Trending News

Building Houston

 
 

The Texas Medical Center Innovation Factory has named the 16 companies making up the inaugural cohort in the Innovate UK Global Incubator Programme. Photo via tmc.edu

Sixteen digital health and medical device startups founded in the United Kingdom have been selected for a customized accelerator at the Texas Medical Center's Innovation Factory.

In partnership with Innovate UK, TMCi created the Innovate UK Global Incubator Programme, a new accelerator that supports UK businesses as they build their United States go-to-market plan. The program builds the BioBridge relationship between TMC and the UK that was originally established five years ago.

“The TMC UK BioBridge program was launched with the UK Department for Business and Trade in 2018 to serve as a gateway for advancing life sciences and foster innovation and research between our two countries," says Ashley McPhail, chief external affairs and administration officer for TMC, in a news release. "We saw an opportunity to work with Innovate UK to develop a larger program with the UK after the success of the 11 companies that previously participated in our health tech accelerator."

The 16 companies will participate in the program from June to November. The cohort is expected to arrive in Houston on June 5 and have access to TMCi's facilities, network of mentors and potential clients, funding, potential customers, and curated programing — all while being a unique entry point into the US. The new offering joins three other globally recognized curriculums: Biodesign, Accelerator for Cancer Therapeutics, and Health Tech.

“TMCi nurtures long-term growth, development, and competitiveness to increase startups chances of success and global expansion," says Emily Reiser, associate director of TMC Innovation. "By bringing their novel technologies and exposing them to a curated selection of TMC’s expert network, startups receive support and evaluation to build, scale, and expand in the US market."

Two of the cohort's specialties include cardiovascular and oncology — two of TMC's strongest areas of expertise — with solutions ranging from surgical devices to AI-enabled risk stratification and hospital efficiency.

Innovate UK is the country's national innovation agency dedicated to supporting business-led innovation in all sectors.

“The United Kingdom is fully committed to improving global healthcare through scientific collaboration," says His Majesty’s Consul General in Texas Richard Hyde in the release. "Through the expansion of the TMC UK BioBridge and in partnership with Innovate UK, this programme will help to expose the brightest and best British companies to the world’s largest medical city. Our companies will collaborate and grow as they work to develop cutting edge technology. The partnership between the UK Government and TMC demonstrates that international collaboration can drive both economic growth and improvement to quality of life.”

The 16 companies making up the inaugural cohort are as follows, according to TMC.

  • AINOSTICS aims to revolutionize the treatment and prevention of neurological conditions, such as dementia, by developing innovative AI-enabled solutions that draw novel insights from routinely acquired non-invasive medical scans to deliver accurate diagnosis and outcome prediction, and in turn facilitate personalized care and timely access to disease-modifying treatments for patients.
  • Alvie is a blended human plus AI-enabled digital solution providing personalised pre and rehabilitation coaching and supportive care for cancer and surgery. Alvie's technology combines data profiling, risk-stratification and tailored prescriptions of health and well-being with curated educational content, targeted behaviour change coaching and expert support through chat messaging and virtual consultations.
  • C the Signs™ is a validated AI cancer prediction platform, which can identify patients at risk of cancer at the earliest and most curable stage of the disease. Used by healthcare professionals, C the Signs can identify which tumor type a patient is at risk of and recommend the most appropriate next step in less than 30 seconds. The platform has detected over 10,000 patients with cancer, with over 50 different types of cancer diagnosed, and with a sensitivity of >98% for cancer.
  • At PEP Health, We believe all patients deserve the best care possible. Our cutting-edge machine-learning technology enables healthcare organisations, regulators, and insurers the real-time, actionable insights they need to have a direct and dramatic impact on patient experiences.
  • PreciousMD improves the lives of lung-cancer and other lung-related illnesses patients worldwide by enabling imaging-based diagnostics needed for personalized treatment pathways.
  • Ufonia is an autonomous telemedicine company, we use large language models and voice AI to increase the capacity of clinical professionals.
  • My mhealth offers digital therapeutics for a range of long-term conditions- COPD, Asthma, Diabetes and Heart Disease. Our product has been successfully deployed in the UK and India, with >100,000 users registered to date. Our solutions empower patients to self-manage their conditions, resulting in dramatic improvements in outcomes, as evidenced through multiple clinical trials and real-world evaluations.
  • At Surgery Hero, we offer a clinically backed solution that ensures whole-human support before and after surgery. We help health systems, employers and health plans cut costs without sacrificing quality of care.
  • Panakeia's software platform enables extremely rapid multi-omics profiling in minutes directly from routinely used tissue images without needing wet lab assays.
  • QV Bioelectronics are striving to deliver longer, better quality lives for brain tumour patients. Using their first-of-its-kind implantable electric field therapy device, GRACE, QV will provide effective, focal & continuous treatment without impacting patient quality of life.
  • 52 North is a med-tech company focused on improving health outcomes and health equity by reinventing care pathways. The NeutroCheck® solution is a finger-prick blood test and digital platform built to significantly improve safety and quality of life for cancer patients, by helping to identify at-home those patients who are at risk of the most fatal side-effect of chemotherapy: neutropenic sepsis.
  • Somnus is fulfilling an unmet need in global healthcare by developing real-time, point of care blood propofol monitoring. Its products will improve the care of sedated and anaesthetised patients, save money for hospitals, and facilitate a major reduction in greenhouse gas emissions.
  • ScubaTx is a breakthrough organ transplant preservation company established to solve the global unmet need for cost-efficient and longer-duration organ preservation technology. ScubaTx has developed a simple, small and affordable device which uses Persufflation to extend the preservation of organs.
  • IBEX is on a mission to help people live active, healthy and productive lives by increasing their access to early diagnosis of osteoporosis. The IBEX BH software as medical device delvers routine, automated assessment of fracture risk from routine radiology for earlier detection and more equitable treatment of osteoporosis.
  • NuVision produces products derived from donated human amniotic membrane that are used in ophthalmology to help patients with chronic, traumatic and post-surgical wounds of the eye to be treated earlier and recover more fully and more quickly. The company’s products are also used in the management of dry eye disease, a debilitating conditions that affects around 17m people in the USA.
  • Calon Cardio-Technology is on a mission to improve quality of life for patients with Left Ventricular Assist devices (LVAD) and reduce the common post operative complications associated with these implantable heart pumps. We plan to do this by introducing a completely wireless heart pump system and augment patient follow-up with built-in remote monitoring capabilities.

Trending News